X

Trial Profile

Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 07 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pbi-shRNA STMN1 lipoplex (Primary)
Indications Cancer
Focus Adverse reactions
Sponsors Gradalis; Strike Bio

Most Recent Events

24 Apr 2017 Status changed from active, no longer recruiting to completed.
07 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov.
07 Apr 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2017, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com